In line with this possibility, a previous report has highlighted an important role of Polκ in sustaining resistance to the alkylating agent temozolomide in glioblastoma through activation of the ATR/Chk1 pathway [89], confirming a previous observation implicating Polκ in Chk1 phosphorylation [38]. The gene discussed is POLK; the disease is glioblastoma.